XML 16 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021   101,136      
Beginning balance at Dec. 31, 2021 $ 387,640 $ 10 $ 576,895 $ (187,314) $ (1,951)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Conversion of Private Warrants 1,104   1,104    
Stock options exercised 36   36    
Vesting of restricted stock units (in shares)   414      
Vesting of restricted stock units (953)   (953)    
Stock-based compensation 6,035   6,035    
Net loss (30,635)     (30,635)  
Other comprehensive income (loss) 4,360       4,360
Ending balance (in shares) at Mar. 31, 2022   101,550      
Ending balance at Mar. 31, 2022 $ 367,587 $ 10 583,117 (217,949) 2,409
Beginning balance (in shares) at Dec. 31, 2022 108,511 108,511      
Beginning balance at Dec. 31, 2022 $ 260,291 $ 11 615,452 (363,960) 8,788
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock, net (in shares)   46,000      
Issuance of common stock, net 43,038 $ 5 43,033    
Stock options exercised (in shares)   391      
Stock options exercised 63   63    
Vesting of restricted stock units (in shares)   182      
Vesting of restricted stock units (79)   (79)    
Stock-based compensation 503   503    
Net loss (33,630)     (33,630)  
Other comprehensive income (loss) $ (1,442)       (1,442)
Ending balance (in shares) at Mar. 31, 2023 155,084 155,084      
Ending balance at Mar. 31, 2023 $ 268,744 $ 16 $ 658,972 $ (397,590) $ 7,346